1. The isolated perfused rat liver efficiently takes up cysteinyl leukotrienes (LTs) C4, D4, E4 and N-acetyl-LTE4 from circulation. More than 70 of these cysteinyl LTs are excreted from liver into bile within I h of onset of a 5 min infusion, while about 5 remain in the liver. About 20 of infused N-acetyl-LTE4 escapes hepatic first-pass extraction under our conditions. 2. Metabolites of LTC4 appearing in bile within 20 min of the onset of infusion include mainly LTD4 and N-acetyl-LTE4, but also w-hydroxy-N-acetyl-LTE4 and o-carboxy-N-acetyl-LTE4. Metabolites generated from w-carboxy-N-acetyl-LTE4 by fl-oxidation from the w-end represent the major biliary LTs secreted at later times. 3. Stimulation of the isolated perfused liver by the combined infusion of the phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) and the Ca2l ionophore A23187 results in a transient increase of endogenous cysteinyl LT production, which is independent of extrahepatic cells. 4. The immunosuppressive drug cyclosporine causes a dose-dependent inhibition of hepatobiliary cysteinyl LT excretion, probably by interference with the sinusoidal uptake system for cysteinyl LTs.
INTRODUCTION
The liver is recognized as a key organ in the elimination and deactivation of leukotrienes (LTs) in vivo [1] [2] [3] [4] .
These eicosanoids mediate various pathophysiological and physiological reactions such as circulatory and respiratory dysfunction, tissue trauma and inflammation [5] [6] [7] [8] [9] . During their short half-life in the circulatio-i [10] [11] [12] [13] , cysteinyl LTs undergo rapid intravascular metabolism yielding LTD and LTE from parent LTC [10, 14, 15] . These cysteinyl LTs are rapidly and efficiently removed from the circulation, predominantly by the liver, and secreted into bile [16] [17] [18] [19] [20] . Local mediator actions of cysteinyl LTs on the liver in vivo contribute to intrahepatic cholestasis [1] and may play a-role in experimental hepatitis [21, 22] . Direct effects of LTC4 and LTD4 were recently demonstrated in the isolated perfused liver, such as increased glucose and lactate output [23] [24] [25] [26] , decreased oxygen uptake [25, 26] and perfusion flow [23] [24] [25] [26] , increased portal pressure [25, 26] and stimulated Ca2" and K+ release [25] .
The contribution of the liver to cysteinyl LT uptake and metabolism has been studied in rats in vivo, mainly with LTC4 [1, 13, 14, [17] [18] [19] 27, 28] , using hepatocytes and hepatoma cells in vitro [29, 30] , and recently also in the isolated perfused liver [24] . Therefore, the first objective of the present study was to monitor the distribution and metabolic pathways of LTC4 as compared with its metabolites LTD4, LTE4 and N-acetyl-LTE4 (LTE4NAc) in the isolated perfused liver. We secondly sought to characterize the liver as a source of endogenous cysteinyl LTs, since rat liver Kupffer cells have recently been demonstrated in vitro as a hepatic site of such endogenous cysteinyl LT production [21, 31, 32] . Thirdly, hepatic transport ofcysteinyl LTs was studied under the influence of the immunosuppressive drug cyclosporine. This compound, widely used in organ transplantation, was earlier shown to interfere with hepatocellular functions including bile acid transport [33] [34] [35] , bile secretion [36, 37] and bilirubin uptake [38] . Since cyclosporine itself is metabolized and eliminated mainly via the liver [39] , we wondered whether cyclosporine also affected hepatic uptake and biliary elimination of cysteinyl LTs.
MATERIALS AND METHODS Animals and materials
Male Wistar rats (200-250 g) were obtained from the Zentralinstitut fur Versuchstiere (Hannover, Germany) and kept as described [18] . [14,15- [41] . In experiments on endogenous LT production, the perfusion medium contained in addition 2 mM-cysteine. Perfusions with cyclosporine or its vehicle were performed with erythrocyte-free medium in a recirculating mode after perfusing the liver essentially free of erythrocytes with about 600 ml of non-recirculated perfusion medium; total recirculating perfusate amounted to 100 ml. Perfusion pressure was constant at about 980 Pa (10 cm U.K.) with a C18-precolumn (Millipore/Waters, Milford, U.S.A.). The mobile phase gradient (solvent system 1) consisted of 0.1 00 (v/v) acetic acid/l mM-EDTA, pH 5.0 (adjusted with ammonium hydroxide) containing, at 0 min, no methanol, switching at 5 min to 4000 (v/v) methanol and reaching 80 0 (v/v) methanol at 40 min. The flow rate was 1 ml/min. Continuous determination of 3H in the h.p.l.c. eluent was performed with a liquid scintillation device (LB 506; Berthold, Wildbad, Germany) using Rialuma scintillation mixture (Baker Chemicals, Gross-Gerau, Germany). The isocratic mobile phase (solvent system 2) used for LT separation before r.i.a. consisted of methanol/water/acetic acid (65:35:0.1, by vol.), containing 1 mM-EDTA, pH 5.6 (adjusted with ammonium hydroxide).
Radioimmunoassay of leukotrienes
Evaporated h.p.l.c. fractions were submitted to r.i.a. as described [12] . The lower detection limit for LTE4 was about 7 fmol, and with the antibody used the relative cross-reactivities of LTE4, LTE4NAc, LTD4 and LTC4 amounted to 100, 144, 160, and 2190 respectively on a molar basis. Concentrations of cysteinyl LTs were calculated according to their individual cross-reactivities in the r.i.a. and corrected for the recovery of [3H]LTs added to each sample prior to h.p.l.c. in amounts not interfering with the r.i.a.
RESULTS

Uptake and biliary excretion of cysteinyl leukotrienes
When livers were perfused via the portal vein (antegrade direction) in a recirculating mode, about 800 of infused cysteinyl LTs were extracted by the liver (Table  1) . This efficient hepatic uptake showed no statistically significant differences between LTC4 and its metabolites 16 and 270% of the administered LT radioactivity was still circulating in the perfusate at I h (Table 1) .
In separate perfusions, we studied hepatic first-pass extraction of [3H]LTE4NAc by collecting total liver effluent during and up to 2 min after LT infusion; after that time livers were perfused in a recirculating mode. Unmetabolized LTC4 amounted to 200% of the radioactivity in this bile sample, and the remaining radioactivity consisted mainly of LTE4NAc and w-carboxyLTE4NAc (Fig. 1a) . LT radioactivity in bile sampled within 60-80 min contained largely metabolites with retention times of 28, 23, and 20 min respectively ( Fig.  1 b) ; these metabolites probably correspond to wo-carboxy-19,20-dinor-LTE4NAc, w-carboxy-17,18,19,20-tetranor-14,15-dihydro-LTE4NAc and w)-carboxy- 17,18,19,20- tetranor-A13-LTE4NAc respectively, as judged from their chromatographic behaviour in an h.p.l.c. solvent system in which these fl-oxidation products of w-carboxyLTE4NAc were recently identified [42] .
After infusion of [3H]LTE4, LT metabolites in bile sampled 0-10 min after onset of tracer infusion were mainly represented by LTE4NAc (70 0%), but small amounts of w-hydroxy-LTE4NAc (4 %) were detected in addition to w-carboxy-LTE4NAc (10%) and its fl-oxidation products; unmetabolized LTE4 could not be detected in bile (Fig. 2) . LT radioactivity in bile collected 40-60 min after the onset of [3H]LTE4 infusion was accounted for mainly by the above-mentioned metabolites generated by fl-oxidation of w-carboxy-LTE4NAc from the w-end (Fig. 2b) (Fig. 2) .
LT radioactivity detected in the liver at 1 Endogenous production of cysteinyl leukotrienes in liver LT production was monitored by measuring immunoreactive cysteinyl LTs after h.p.l.c. separation of bile. Biliary LTs were determined in samples collected before and up to 1 h after stimulation of the liver. In comparison with biliary cysteinyl LT concentrations from unstimulated control liver (Fig. 3a) , increased amounts of cysteinyl LTs were generated and excreted into bile after stimulation of the liver by the combined infusion of the phorbol ester TPA (300 nmol/kg body wt.) and the Ca2" ionophore A23187 (60 nmol/kg body wt.) (Fig. 3b) Inhibition of hepatobiliary leukotriene elimination by cyclosporine
The effect of cyclosporine on the uptake and biliary excretion of cysteinyl LTs was studied by adding the drug or its vehicle to the perfusate 30 (Fig. 2) .
DISCUSSION
The present investigation demonstrates and extends findings that the liver constitutes the main organ involved in the uptake of cysteinyl LTs from circulation, their metabolism and deactivation, and is also a potential site of endogenous cysteinyl LT generation. Metabolism of cysteinyl LTs in the liver includes intravascular formation of LTD4 and LTE4 [24] and proceeds in rat hepatocytes to LTE4NAc [2, 19, 27] and its wo-oxidation products, w-hydroxy-LTE4NAc and co-carboxy-LTE4NAc [4, 24, 28, [44] [45] [46] [47] . While LTC4 [24] and LTD4 can pass from the circulation via hepatocytes into bile partially unmetabolized (Figs. 1 and 2 ), intrahepatic N-acetylation of LTE4 is very active before biliary secretion so that LTE4 is not detectable in bile after LTE4 infusion (Fig. 2) . Hepatocellular w-oxidation of LTE4NAc to wo-carboxy-LTE4NAc via wo-hydroxyLTE4NAc also appears to occur rapidly as judged from the relative biliary amounts of these metabolites ( Figs. 1  and 2 ). The subsequent shortening of the fatty acid backbone of cysteinyl LTs by fl-oxidation from the wo-end [4, 42, 46, 47] becomes apparent only in late bile samples ( Figs. 1 and 2 ) and agrees with the earlier finding in vivo that these polar LT metabolites in bile increase in proportion with time [14, 18] .
The liver is not only a target organ for extracting, metabolizing and responding to eicosanoids [1-5,13-20, 22-28,43,47-54] , but is in addition able to produce these potent mediators, as shown for prostanoids [31, [52] [53] [54] [55] [56] [57] [58] and LTs [21, 31, 32] . Stimulation of endogenous LT production in the isolated perfused organ by the combined action of TPA and A23187 (Fig. 3) confirms this hepatic capacity and is in line with the described synergistic effect of these agents on LT production [59, 60] . As with prostanoid formation in the isolated perfused liver [52-571, the enhanced hepatic LT generation was transient and independent of extrahepatic cells (Fig.  3) . Since w)-oxidation metabolites of cysteinyl LTs escape our radioimmunological detection, the measured amounts ofcysteinyl LTs may well be an underestimation of the originally producted LTs.
The inhibitory action of the immunosuppressive drug cyclosporine on hepatobiliary LT secretion (Table 2) can be dissociated from its cholestatic effect [36, 37] as the former was also observed at a cyclosporine dose not affecting bile flow. Cyclosporine exerts its inhibitory action most likely on the sinusoidal uptake system for cysteinyl LTs, since the circulating extrahepatic LTE4 remained unmetabolized, whereas LTs in liver and bile indicated normal intrahepatic LTE4 metabolism under this condition. Cyclosporine is known to interfere with several hepatocellular transport systems located at the sinusoidal surface [33] [34] [35] . In addition, cyclosporine may also affect hepatocellular transport systems at the canalicular surface, as indicated by recent studies on bile acid excretion from hepatocytes [61] . This is in line with our observation that cyclosporine causes an up to 14-fold decrease in the bile/liver ratio of LT radioactivity as compared with controls ( Table 2 ). The demonstrated action of cyclosporine on hepatic LT extraction in the isolated perfused organ was confirmed in preliminary studies in vivo (results not shown) and affects the major route of deactivation and elimination of these eicosanoids. A prolonged biological activity ofcirculating LTs due to cyclosporine may be critical to the affected organism under conditions of enhanced systemic production of these pro-inflammatory mediators, such as surgical trauma and bacterial infection [11, 18] .
